Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy

Rituximab monotherapy is widely used for follicular lymphoma. However, there are no established predictors for response or response duration. We analyzed the long-term prognostic relevance of pre-treatment absolute blood counts of lymphocytes with subsets and monocytes in 265 follicular lymphoma pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Junlén, Henna-Riikka, Lockmer, Sandra, Kimby, Eva, Wahlin, Björn Engelbrekt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481163/
https://www.ncbi.nlm.nih.gov/pubmed/32808106
http://dx.doi.org/10.1007/s00277-020-04208-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481163/
https://www.ncbi.nlm.nih.gov/pubmed/32808106
http://dx.doi.org/10.1007/s00277-020-04208-x

Ejemplares similares